Unknown PHASE1 INTERVENTIONAL 1-arm NCT04863066

Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection (TCTIWHI)

A Phase I Trial Using Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection

Sponsor: Beijing 302 Hospital

Conditions HIV-1

Interventions CAR-T cells

Updated 4 times since 2021 Last updated: Apr 25, 2021 Started: May 1, 2021 Primary completion: Jun 15, 2022 Completion: Oct 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates HIV-1 and is currently ongoing. Beijing 302 Hospital leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status
May 2021 — Nov 2022 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing 302 Hospital
Tsinghua University

Data source: Beijing 302 Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China